Literature DB >> 9888457

Tumour markers of prognosis in colorectal cancer.

H L McLeod1, G I Murray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9888457      PMCID： PMC2362193          DOI： 10.1038/sj.bjc.6690033

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  97 in total

1.  The prognostic significance of direct extension of carcinoma of the colon and rectum.

Authors:  V B ASTLER; F A COLLER
Journal:  Ann Surg       Date:  1954-06       Impact factor: 12.969

2.  P53 in tumour pathology: can we trust immunocytochemistry?

Authors:  D Wynford-Thomas
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

3.  Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.

Authors:  P G Johnston; J C Drake; J Trepel; C J Allegra
Journal:  Cancer Res       Date:  1992-08-15       Impact factor: 12.701

4.  ras and c-myc protein expression in colorectal carcinoma. Study of cancer-prone patients.

Authors:  F Miller; T M Heimann; A Quish; D J Pyo; A Szporn; G Martinelli; T M Fasy
Journal:  Dis Colon Rectum       Date:  1992-05       Impact factor: 4.585

5.  Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival.

Authors:  C S McArdle; D Hole
Journal:  BMJ       Date:  1991-06-22

6.  ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma.

Authors:  M A Bennett; E W Kay; H Mulcahy; L O'flaherty; D P O'donoghue; M Leader; D T Croke
Journal:  Clin Mol Pathol       Date:  1995-12

7.  ras p21 expression in relation to DNA ploidy, S-phase fraction and prognosis in colorectal adenocarcinoma.

Authors:  X F Sun; S Wingren; J M Carstensen; O Stål; T Hatschek; B Boeryd; B Nordenskjöld; H Zhang
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

8.  Association of genetic alterations of c-myc, c-fos, and c-Ha-ras proto-oncogenes in colorectal tumors. Frequency and clinical significance.

Authors:  M A Nagai; A Habr-Gama; C T Oshima; M M Brentani
Journal:  Dis Colon Rectum       Date:  1992-05       Impact factor: 4.585

9.  DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinoma.

Authors:  T E Witzig; C L Loprinzi; N J Gonchoroff; H M Reiman; S S Cha; H S Wieand; J A Katzmann; J K Paulsen; C G Moertel
Journal:  Cancer       Date:  1991-08-15       Impact factor: 6.860

10.  Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma.

Authors:  X F Sun; J M Carstensen; H Zhang; O Stål; S Wingren; T Hatschek; B Nordenskjöld
Journal:  Lancet       Date:  1992-12-05       Impact factor: 79.321
View more
  44 in total

1.  Oncocytic modifications in rectal adenocarcinomas after radio and chemotherapy.

Authors:  Andrea Ambrosini-Spaltro; Fabrizio Salvi; Christine M Betts; Giovanni P Frezza; Antonio Piemontese; Pietro Del Prete; Cristina Baldoni; Maria P Foschini; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-12-20       Impact factor: 4.064

Review 2.  Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review.

Authors:  L Ung; A K-Y Lam; D L Morris; T C Chua
Journal:  Clin Transl Oncol       Date:  2014-01-24       Impact factor: 3.405

3.  Dilated SMV in colon cancer--is there any significance.

Authors:  Aman N Khan; Rajesh Botchu; Roshni Patel; Mosheir Elabassy
Journal:  J Gastrointest Cancer       Date:  2012-06

4.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer.

Authors:  T Watanabe; T T Wu; P J Catalano; T Ueki; R Satriano; D G Haller; A B Benson; S R Hamilton
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

Review 5.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

6.  Overexpression of S100A4 is closely associated with progression of colorectal cancer.

Authors:  Yong-Gu Cho; Chang-Jae Kim; Suk-Woo Nam; Shin-Hee Yoon; Sug-Hyung Lee; Nam-Jin Yoo; Jung-Young Lee; Won-Sang Park
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

7.  Bayesian variable selection with joint modeling of categorical and survival outcomes: an application to individualizing chemotherapy treatment in advanced colorectal cancer.

Authors:  Wei Chen; Debashis Ghosh; Trivellore E Raghunathan; Daniel J Sargent
Journal:  Biometrics       Date:  2009-12       Impact factor: 2.571

8.  Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.

Authors:  C K Kontos; I N Papadopoulos; E G Fragoulis; A Scorilas
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

9.  Analysis of neuroendocrine differentiation and the p53/BAX pathway in UICC stage III colorectal carcinoma identifies patients with good prognosis.

Authors:  Patricia Grabowski; Isrid Sturm; Katharina Schelwies; Kerstin Maaser; Heinz-Johannes Buhr; Bernd Dörken; Martin Zeitz; Peter T Daniel; Hans Scherübl
Journal:  Int J Colorectal Dis       Date:  2005-06-14       Impact factor: 2.571

10.  Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.

Authors:  Y J Fang; Z H Lu; G Q Wang; Z Z Pan; Z W Zhou; J P Yun; M F Zhang; D S Wan
Journal:  Int J Colorectal Dis       Date:  2009-05-07       Impact factor: 2.571
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.